[1] 钱军, 刁畅, 马云海, 等.  甲状腺结节诊断评估模式的演变[J]. 国际外科学杂志, 2013, 40(2): 75-77.   doi: 10.3760/cma.j.issn.1673-4203.2013.02.002
Qian J, Diao C, Ma YH, et al.  Evolution of diagnostic evaluation models for thyroid nodules[J]. Int J Surg, 2013, 40(2): 75-77.   doi: 10.3760/cma.j.issn.1673-4203.2013.02.002
[2] 蒲昭和.  哪些中成药治甲状腺结节?[J]. 中南药学(用药与健康), 2016, (12): 55-.
Pu ZH.  Which traditional Chinese patent medicines and simple preparations treat thyroid nodules?[J]. Med Health, 2016, (12): 55-.
[3] 侯振江, 李卫东.  关注甲状腺癌危险因素防癌治癌提高全民健康水平[J]. 医学综述, 2020, 26(23): 4577-4581, 4587.   doi: 10.3969/j.issn.1006-2084.2020.23.001
Hou ZJ, Li WD.  Pay attention to thyroid cancer risk factors, prevent and treat cancer, improve public health[J]. Med Recapitulate, 2020, 26(23): 4577-4581, 4587.   doi: 10.3969/j.issn.1006-2084.2020.23.001
[4] 杨帆, 邵茜, 杜莉.  超声检查在甲状腺癌鉴别诊断的临床价值[J]. 医学影像学杂志, 2020, 30(12): 2327-2330.
Yang F, Shao Q, Du L.  Clinical value of ultrasonography in differential diagnosis of thyroid carcinoma[J]. J Med Imaging, 2020, 30(12): 2327-2330.
[5] 叶蕾, 李浩榕.  良恶性甲状腺结节的分子鉴别诊断进展[J]. 诊断学理论与实践, 2020, 19(4): 334-338.   doi: 10.16150/j.1671-2870.2020.04.002
Ye L, Li HR.  Advances in molecular differential diagnosis of benign and malignant thyroid nodules[J]. J Diagn Concepts Pract, 2020, 19(4): 334-338.   doi: 10.16150/j.1671-2870.2020.04.002
[6] Botha M, Kisansa M, Greeff W.  American college of radiology thyroid imaging reporting and data system standardises reporting of thyroid ultrasounds[J]. SA J Radiol, 2020, 24(1): 1804-.   doi: 10.4102/sajr.v24i1.1804
[7] Russ G, Bonnema SJ, Erdogan MF, et al.  European thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS[J]. Eur Thyroid J, 2017, 6(5): 225-237.   doi: 10.1159/000478927
[8] 傅强, 熊颖, 宋可馨, 等.  ACR-TIRADS、EU-TIRADS及KTA/KSThR-TIRADS评估甲状腺结节一致性的研究[J]. 中华医学超声杂志(电子版), 2020, 17(7): 684-690.   doi: 10.3877/cma.j.issn.1672-6448.2020.07.018
Fu Q, Xiong Y, Song KX, et al.  Interobserver variability in sonographic evaluation of thyroid nodules with ACR-TI-RADS, EU-TIRADS and KTA/KSThR-TIRADS[J]. Chin J Med Ultrasound: Electr Ed, 2020, 17(7): 684-690.   doi: 10.3877/cma.j.issn.1672-6448.2020.07.018
[9] Tessler FN, Middleton WD, Grant EG, et al.  ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee[J]. J Am Coll Radiol, 2017, 14(5): 587-595.   doi: 10.1016/j.jacr.2017.01.046
[10] 何瑞琦, 陈英银, 叶云英, 等.  超声TI-RADS分级对甲状腺结节良恶性的鉴别诊断价值[J]. 现代医用影像学, 2020, 29(5): 938-942.
He RQ, Chen YY, Ye YY, et al.  Value of ultrasound TI-RADS classification for differential diagnosis of benign and malignant thyroid nodules[J]. Mod Med Imageology, 2020, 29(5): 938-942.
[11] 施秉银.  甲状腺结节: 从迷茫到清晰[J]. 国际内分泌代谢杂志, 2022, 42(2): 93-95.   doi: 10.3760/cma.j.cn121383-20210208-02005
Shi BY.  Thyroid nodule: from confusion to clarity[J]. Int J Endocrinol Metab, 2022, 42(2): 93-95.   doi: 10.3760/cma.j.cn121383-20210208-02005
[12] Lee JC, Grodski S, Yeung M, et al.  Response to the letter to the editor regarding “Quantitative study of voice dysfunction after thyroidectomy”[J]. Surgery, 2017, 162(3): 692-693.   doi: 10.1016/j.surg.2017.03.022
[13] 陈夏珊, 陈卉品, 陈江华.  ACR-TIRADS与EU-TIRADS分类对甲状腺结节的诊断价值比较[J]. 中国医学影像学杂志, 2021, 29(8): 770-775.   doi: 10.3969/j.issn.1005-5185.2021.08.003
Chen XS, Chen HP, Chen JH.  Diagnosis of American College of Radiology and European thyroid imaging reporting and data system classification in thyroid nodes: a comparative study[J]. Chin J Med Imaging, 2021, 29(8): 770-775.   doi: 10.3969/j.issn.1005-5185.2021.08.003
[14]

Schenke S, Klett R, Seifert P, et al. Diagnostic performance of different thyroid imaging reporting and data systems (Kwak-TIRADS, EU-TIRADS and ACR TI-RADS) for risk stratification of small thyroid nodules (≤10 mm)[J/OL]. J Clin Med, 2020, 9(1): 236[2022-12-20]. https://www.mdpi.com/2077-0383/9/1/236. DOI: 10.3390/jcm9010236.

[15]

Shen Y, Liu M, He J, et al. Comparison of different risk-stratification systems for the diagnosis of benign and malignant thyroid nodules[J/OL]. Front Oncol, 2019, 9: 378[2022-12-20]. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2019.00378/full. DOI: 10.3389/fonc.2019.00378.